November 14, 2017
Kenporen Director Shoji Kono (center) The government should impose deeper cuts on the prices of off-patent brand-name drugs, dubbed long-listed products (LLPs), while abolishing the current five-year grace period, a vocal member of the Central Social Insurance Medical Council, a...read more